Abstract
Background/objectives
The present cross-sectional study evaluated the association of vitamin D receptor (VDR) variants with serum 25(OH)D3 levels and their interaction on essential hypertension (EH) risk.
Subjects/methods
1539 patients were eligible in the study population. Two loci in VDR gene (rs2239179, rs2189480) were genotyped by TaqMan probe assays. Logistic regression, Kruskal–Wallis rank test and Chi-square test were used to determine the association among VDR polymorphisms, serum vitamin D metabolites, and the risk of EH. Interaction plots were performed to explain the interaction effects of circulating 25(OH)D3 levels and VDR variants on EH susceptibility.
Results
After potential confounding adjustment, we observed that the mutations of VDR (rs2239179/rs2189480) were associated with the increased risk of EH (P < 0.05). Moreover, plasma 25(OH)D3 levels were inversely associated with EH, However, we did not find the association between serum 25(OH)D3 and VDR variants. When comparing with wild-type homozygous and heterozygous genotype carriers with vitamin D sufficiency, hypovitaminosis D and insufficient participants carrying homozygous variant genotype of rs2239179 showed a higher risk of EH, increased by 113% (OR = 2.13, 95% CI: 1.20, 3.80); Notably, the detrimental effect of rs2239179 homozygous variant on EH became stronger in the case of serum 25(OH)D3 <30 ng/ml. However, we did not find the interaction effect between rs2189480 variants and serum 25(OH)D3 levels on the risk of EH.
Conclusions
Our results suggested that the mutations of VDR may accelerate the progression of EH etiology, especially when suffering hypovitaminnosis D and insufficiency.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chen S. Essential hypertension: perspectives and future directions. J Hypertens. 2012;30:42–5. https://doi.org/10.1097/HJH.0b013e32834ee23c.
WHO: Cardiovascular disease, World Health Organization; 2013. https://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/.
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.
Legarth C, Grimm D, Wehland M, Bauer J, Krüger M. The impact of Vitamin D in the treatment of essential hypertension. Int J Mol Sci. 2018;19:455.
Ke L, Mason RS, Mpofu E, Vingren JL, Li Y, Graubard BI, et al. Hypertension and other cardiovascular risk factors are associated with vitamin D deficiency in an urban Chinese population: a short report. J Steroid Biochem Mol Biol. 2017;173:286–91.
McMullan CJ, Borgi L, Curhan GC, Fisher N, Forman JP. The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial. J Hypertens. 2017;35:822–9.
Norman AW. The history of the discovery of Vitamin D and its daughter steroid hormone. Ann Nutr Metab. 2012;61:199–206.
Smith CP, Hyppönen E, Chope G, Bucca G, Lambert H, Berry J, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95:1357–64.
Brumbaugh PF, Haussler MR. 1α,25-dihydroxycholecalciferol receptors in intestine: I. association OF 1α,25-dihydroxycholecalciferol with intestinal mucosa chromatin. J Biol Chem. 1974;249:1251–7.
Arnold AC, Gallagher PE, Diz DI. Brain renin-angiotensin system in the nexus of hypertension and aging. Hypertens Res. 2013;36:5–13.
Li YC, Kong J, Wei M, Chen Z-F, Liu SQ, Cao L-P. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Investig. 2002;110:229–38.
Jia J, Shen C, Mao L, Yang K, Men C, Zhan Y. Vitamin D receptor genetic polymorphism is significantly associated with decreased risk of hypertension in a Chinese Han population. J Clin Hypertens. 2014;16:634–9.
Wang L, Ma J, Manson JE, Buring JE, Gaziano JM, Sesso HD. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr. 2013;52:1771–9.
Kim T-H, Lee H-H, Kim J-M, Hwang J-Y, Mun MJ. Relationship between preeclampsia, gestational hypertension, and vitamin D receptor (VDR) gene polymorphisms. Arch Gynecol Obstet. 2015;292:717–8.
Rezavand N, Tabarok S, Rahimi Z, Vaisi-Raygani A, Mohammadi E, Rahimi Z. The effect of VDR gene polymorphisms and vitamin D level on blood pressure, risk of preeclampsia, gestational age, and body mass index. J Cell Biochem. 2019;120:6441–8.
Frederick S, Yue H, Brenton K. Interplot: plot the effects of variables in interaction terms. R package version 0.2.1.2018. https://CRAN.R-project.org/package=interplot.
Chen S, Sun Y, Agrawal DK. Vitamin D deficiency and essential hypertension. J Am Soc Hypertens. 2015;9:885–901.
Rai V, Agrawal DK. Role of vitamin D in cardiovascular diseases. Endocrinol Metab Clin North Am. 2017;46:1039–59.
Sun H, Long SR, Li X, Ge H, Liu X, Wang T, et al. Serum vitamin D deficiency and vitamin D receptor gene polymorphism are associated with increased risk of cardiovascular disease in a Chinese rural population. Nutr Res. 2019;61:13–21.
Karonova T, Grineva E, Belyaeva O, Bystrova A, Jude EB, Andreeva A, et al. Relationship between vitamin D status and vitamin D receptor gene polymorphisms with markers of metabolic syndrome among adults. Front Endocrinol. 2018;9:448.
Ke L, Graubard BI, Albanes D, Fraser DR, Weinstein SJ, Virtamo J, et al. Hypertension, pulse, and other cardiovascular risk factors and vitamin D status in Finnish men. Am J Hypertens. 2013;26:951–6.
Wang Y, Yu F, Yu S, Zhang D, Wang J, Han H, et al. Triangular relationship between CYP2R1 gene polymorphism, serum 25(OH)D3 levels and T2DM in a Chinese rural population. Gene. 2018;678:172–6.
Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet. 2005;42:737–48.
Fitzsimons JT. Angiotensin stimulation of the central nervous system. In: Reviews of physiology, biochemistry and pharmacology, volume 87. Berlin, Heidelberg: Springer;1980. p. 117–67.
Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 1972;286:441–9.
Ni W, Watts SW, Ng M, Chen S, Glenn DJ, Gardner DG. Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension. 2014;64:1290–8.
Vaidya A, Sun B, Forman JP, Hopkins PN, Brown NJ, Kolatkar NS, et al. The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians. Clin Endocrinol. 2011;74:783–90.
Cottone S, Guarino L, Arsena R, Scazzone C, Tornese F, Guarneri M, et al. Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals. J Hum Hypertension. 2014;29:483.
Margolis KL, Martin LW, Ray RM, Kerby TJ, Allison MA, Curb JD, et al. A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol. 2012;175:22–32.
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–8.
Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28:205–21. https://doi.org/10.1007/s10654-013-9790-2.
Vaidya A, Williams JS. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metab Clin Exp. 2012;61:450–8.
Carrara D, Bruno RM, Bacca A, Taddei S, Duranti E, Ghiadoni L, et al. Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D. J Hypertens. 2016;34:2199–205.
Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1α-hydroxylase knockout mice. Kidney Int. 2008;74:170–9.
Yang D, Anderson PH, Wijenayaka AR, Barratt KR, Triliana R, Stapledon CJM, et al. Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D3 on osteoblast differentiation. J Steroid Biochem Mol Biol. 2018;177:83–90.
Girgis CM, Mokbel N, Cha KM, Houweling PJ, Abboud M, Fraser DR, et al. The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology. 2014;155:3227–37.
Chen S, Glenn DJ, Ni W, Grigsby CL, Olsen K, Nishimoto M, et al. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension. 2008;52:1106–12.
Batai K, Murphy AB, Shah E, Ruden M, Newsome J, Agate S, et al. Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum Genet. 2014;133:1395–405.
Zhang Z, He J-W, Fu W-Z, Zhang C-Q, Zhang Z-L. An analysis of the association between the vitamin D pathway and serum 25-hydroxyvitamin D levels in a healthy Chinese population. J Bone Miner Res. 2013;28:1784–92.
Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc. 2012;72:89–97.
Tosh AK, Belenchia AM, Hillman LS, Peterson CA. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr. 2013;97:774–81.
Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA. 2012;308:1898–905.
Vimaleswaran KS, Power C, Hyppönen E. Interaction between vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D concentrations on metabolic and cardiovascular disease outcomes. Diabetes Metab. 2014;40:386–9.
Xia S-l, Lin X-x, Guo M-d, Zhang D-g, Zheng S-z, Jiang L-j, et al. Association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with Crohn's disease in Chinese patients. J Gastroenterol Hepatol. 2016;31:795–801.
Xia Z, Man Q, Li L, Song P, Jia S, Song S, et al. Vitamin D receptor gene polymorphisms modify the association of serum 25-hydroxyvitamin D levels with handgrip strength in the elderly in Northern China. Nutrition. 2019;57:202–7.
Acknowledgements
We thank the supporters and applicants of this project.
Funding
XL and FS wrote the paper; YW and FY involved in genotyping; CG and XL contributed in dealing with data; FS, XL, and FY were responsible for collecting data; WL, YB, and CW reviewed this paper.
Author information
Authors and Affiliations
Contributions
This work was supported by the National Nature Science Foundation of China (grants number 81573151, 81872626, and 81573243), Science and Technology Foundation for Innovation Talent of Henan Province (No. 154200510010).
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Shen, F., Guo, C., Wang, Y. et al. Low serum 25-hydroxyvitamin D levels may increase the detrimental effect of VDR variants on the risk of essential hypertension. Eur J Clin Nutr 74, 1091–1099 (2020). https://doi.org/10.1038/s41430-019-0543-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-019-0543-5
This article is cited by
-
Vitamin D levels and vitamin D receptor genetic variants in Egyptian cardiovascular disease patients with and without diabetes
Egyptian Journal of Medical Human Genetics (2021)
-
The influence of VDR polymorphisms on the type 2 diabetes susceptibility in Chinese: an interaction with hypertriglyceridemia
Molecular Genetics and Genomics (2021)